Abstract:One of the universal characteristics of the long bones and spines of middle-age and older mammals is a loss in bone mass (osteopenia). In humans, if this bone loss is severe enough, it results in osteoporosis, a skeletal disorder characterized by a markedly increased incidence of fractures with sequelae that may include pain, loss of mobility, and in the event of hip fracture, even death within a relatively few months of injury. An important contributing factor to the development of osteoporosis appears to be a diminution in the number and activity of osteoblasts responsible for synthesizing new bone matrix. The findings in the present and other similar studies suggest that this reduction in osteoblast number and activity is due to an age-related diminution in the size and osteogenic potential of the bone marrow osteoblast progenitor cell (OPC or CFU-f) compartment. We previously postulated that these regressive changes in the OPC/CFU-f compartment occurred in old animals because of a reduction in the amount and/or activity of TGF-beta1, an autocrine growth factor important in the promotion of OPC/CFU-f proliferation and differentiation. In support of this hypothesis, we now report that (1) the osteogenic capacity of the bone marrow of 24-month-old BALB/c mice, as assessed in vivo, is markedly reduced relative to that of 3-4-month-old animals, (2) that the matrix of the long bones of old mice contains significantly less TGF-beta than that of young mice, (3) that OPC's/CFU-f's isolated from old mice produce less TGF-beta in vitro than those recovered from young mice, and (4) that OPC's/CFU-f's from old mice express significantly more TGF-beta receptor (Types I, II, and III) than those of young animals and that such cells are more responsive in vitro to exogenous recombinant TGF-beta1. We also find that colony number and proliferative activity of OPC's/CFU-f's of young mice and old mice, respectively, are significantly reduced when incubated in the presence of neutralizing TGF-beta1 antibody. Collectively, these data are consistent with the hypothesis that in old male mice the reduction in the synthesis and, perhaps, availability from the bone matrix of TGF-beta1 contributes to a diminution in the size and development potential of the bone marrow osteoprogenitor pool.

Endothelial BMAL1 decline during aging leads to bone loss by destabilizing extracellular fibrillin-1

The age-related characteristics in bone microarchitecture, osteoclast distribution pattern, functional and transcriptomic alterations of BMSCs in mice

BMAL1-TTK-H2Bub1 Loop Deficiency Contributes to Impaired BM-MSC-mediated Bone Formation in Senile Osteoporosis

Age-related BMAL1 Change Affects Mouse Bone Marrow Stromal Cell Proliferation and Osteo-Differentiation Potential.

miR-155-5p/Bmal1 Modulates the Senescence and Osteogenic Differentiation of Mouse BMSCs through the Hippo Signaling Pathway

Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways

Regulatory cellular and molecular networks in the bone microenvironment during aging

CCL3 in the bone marrow microenvironment causes bone loss and bone marrow adiposity in aged mice

Age-related Changes in Bone Marrow Mesenchymal Stromal Cells

Matrix-bound Cyr61/CCN1 is required to retain the properties of the bone marrow mesenchymal stem cell niche but is depleted with aging

Transcriptomic alterations underline aging of osteogenic bone marrow stromal cells

Aging impairs the osteocytic regulation of collagen integrity and bone quality

Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging.

Deletion of the transcription factor EBF1 in perivascular stroma disrupts skeletal homeostasis and precipitates premature aging of the marrow microenvironment

BMAL1 regulates osteoblast differentiation through mTOR/GSK3/-catenin pathway

Activation of 4-1BB signaling in bone marrow stromal cells triggers bone loss via the p-38 MAPK-DKK1 axis in aged mice

BMAL1 Regulates Osteoblast Differentiation Through Mtor/gsk3β/β-Catenin Pathway.

CD11B+CD36+ cells are bone anabolic macrophages that limit age-associated bone loss

Bone loss (osteopenia) in old male mice results from diminished activity and availability of TGF-beta

Dysfunction of metabolic activity of bone marrow mesenchymal stem cells in aged mice

Age-related changes in the osteogenic differentiation potential of mouse bone marrow stromal cells.